Drug Type Small molecule drug |
Synonyms- |
Mechanism CDK12 inhibitors(cyclin dependent kinase 12 inhibitors), CDK13 inhibitors(CHED protein kinase inhibitors), CDK9 inhibitors(Cyclin-dependent kinase 9 inhibitors) + [3] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | - | 21 Jan 2023 |